Suppr超能文献

Rationale for interleukin-6 blockade in systemic lupus erythematosus.

作者信息

Tackey E, Lipsky P E, Illei G G

机构信息

Office of the Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, USA.

出版信息

Lupus. 2004;13(5):339-43. doi: 10.1191/0961203304lu1023oa.

Abstract

Interleukin-6 (IL-6) is a pleiotropic cytokine with a wide range of biological activities that plays an important role in immune regulation and inflammation. Among other actions, it induces terminal differentiation of B lymphocytes into antibody-forming cells and the differentiation of T cells into effector cells. IL-6 also has multiple potent proinflammatory effects. An association between IL-6 and lupus was demonstrated in murine models of SLE and blocking IL-6 improved lupus in all models tested. Data from several studies suggest that IL-6 plays a critical role in the B cell hyperactivity and immunopathology of human SLE, and may have a direct role in mediating tissue damage. Based on these data, we propose that blocking the effect of IL-6 in humans may improve lupus by interacting with the autoinflammatory process both systemically and locally.

摘要

相似文献

1
Rationale for interleukin-6 blockade in systemic lupus erythematosus.
Lupus. 2004;13(5):339-43. doi: 10.1191/0961203304lu1023oa.

引用本文的文献

本文引用的文献

2
The paradigm of IL-6: from basic science to medicine.白细胞介素-6的范例:从基础科学到医学
Arthritis Res. 2002;4 Suppl 3(Suppl 3):S233-42. doi: 10.1186/ar565. Epub 2002 May 9.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验